HomeMLYS • NASDAQ
add
Mineralys Therapeutics Inc
Previous close
$13.07
Day range
$12.98 - $13.27
Year range
$5.85 - $17.44
Market cap
652.65M USD
Avg Volume
147.74K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 35.36M | 136.73% |
Net income | -31.51M | -149.90% |
Net profit margin | — | — |
Earnings per share | -0.70 | -37.25% |
EBITDA | -35.35M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 338.56M | 25.10% |
Total assets | 347.25M | 13.32% |
Total liabilities | 19.20M | 81.86% |
Total equity | 328.04M | — |
Shares outstanding | 49.65M | — |
Price to book | 1.98 | — |
Return on assets | -29.52% | — |
Return on capital | -31.06% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -31.51M | -149.90% |
Cash from operations | -19.14M | -49.82% |
Cash from investing | -55.95M | 60.11% |
Cash from financing | 116.20M | -42.92% |
Net change in cash | 41.11M | -18.66% |
Free cash flow | -6.96M | 13.34% |
About
Founded
2019
Website
Employees
28